Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NP2GO vs PlexusDx

NP2GO
Graded #37

Higher grade

vs+12.5
PlexusDx
Graded #158

Lower grade

The verdict

NP2GO takes it — 80.2/100 to 67.7/100.

NP2GO grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Both molecules across 40 states, but upper-mid pricing and no verification listing.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNP2GO +7
81
74
Dose & formulationNP2GO +16
80
64
Clinical oversightNP2GO +5
79
74
Labs & monitoringNP2GO +26
78
52
FulfillmentNP2GO +4
82
78
Contract termsNP2GO +27
82
55
NP2GO · left barPlexusDx · right bar

The numbers

MetricNP2GOPlexusDx
WeighScore80.2/10067.7/100
GradeB−C
Scorecard rank#37#158
Semaglutide$150/mo$149/mo (starting dose, compounded)
Tirzepatide$250/mo$249/mo (starting dose, compounded)
Coverage40 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
NP2GO

Graded #37 · B−

Strengths

  • Both molecules
  • 40-state footprint
  • Transparent listed pricing

Where it loses points

  • Not LegitScript-verified
  • Upper-mid pricing ($150/$250)
  • Not all 50 states
PlexusDx

Graded #158 · C

Strengths

  • Licensed providers available in all 50 states
  • Range of options including low-cost microdose GLP-1 from $129/mo
  • Optional Precision Peptide genetic panel adds a personalization angle
  • Independent clinician review via state-licensed telehealth platform
  • Compounded medications from state-licensed pharmacies

Where it loses points

  • Compounded medications only; no FDA-approved brand options
  • Specific compounding pharmacies not named
  • Genetic-panel upsell may not add clinical value for everyone
  • Tirzepatide pricing from $249/mo is higher than budget rivals
  • No insurance accepted

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard